A prospective randomized study on the mobilization of CD34+ cells comparing continuous intravenous vs subcutaneous administration of rhG-CSF in normal donors

Bone Marrow Transplantation

Volumn 36, Issue 12, 2005, Pages 1027-1031

  Lee, K E ^a   Mun, Y C ^a   Nam, S H ^a   Kwon, J M ^a   Lee, S M ^a   Lee, M A ^a   Yoo, E S ^a   Ahn, J Y ^a   Kim, J H ^b   Seong, C M ^a  

^a Ewha Womans University   (South Korea)

^b Korea University   (South Korea)

Author keywords

CD34+ cells; Continuous IV rhG CSF; Mobilization; Normal individuals

Indexed keywords

CD34 ANTIGEN; PARACETAMOL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; BLOOD CELL COUNT; BONE PAIN; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; FATIGUE; HEADACHE; HUMAN; HUMAN EXPERIMENT; LEUKOCYTE; LIVER DYSFUNCTION; LIVING DONOR; NAUSEA; NORMAL HUMAN; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STEADY STATE; STEM CELL MOBILIZATION;

ADOLESCENT; ADULT; ANTIGENS, CD34; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; IMMUNOPHENOTYPING; INFUSIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; KINETICS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PHENOTYPE; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 30544446066     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705186     Document Type: Article

References (26)

1. Kröger N, Renges H, Kruger W et al. A randomized comparison of once vs twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation. Br J Haematol 2000; 111: 761-765.
2. de la Rubia J, Arbona C, de Arriba F et al. Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors. Transfusion 2002; 42: 4-9.
3. + peripheral blood progenitor cells in normal donors. Br J Haematol 2000; 109: 770-772.
4. Martinez C, Urbano-Ispizua A, Marin P et al. Efficacy and toxicity of a high-dose G-CSF schedule for peripheral blood progenitor cell mobilization in healthy donors. Bone Marrow Transplant 1999; 24: 1273-1278.
5. + immunoselection. J Clin Oncol 1999; 17: 2160-2172.
6. Watts MJ, Addison I, Long SG et al. Crossover study of the haematological effects and pharmacokinetics of glycosylated and non-glycosylated G-CSF in healthy volunteers. Br J Haematol 1997; 98: 474-479.
7. de Haas M, Kerst JM, ven der Schoot CE et al. Granulocyte colony-stimulating factor administration to healthy volunteers: Analysis of the immediate activating effects on circulating neutrophils. Blood 1994; 84: 3885-3894.
8. van der Auwera P, Platzer E, Xu ZX et al. Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF Mutant (Ro 25-8315) in healthy volunteers: Comparison with single and multiple daily doses of filgrastim. Am J Hematol 2001; 66: 245-251.
9. + cells in association with modulation of CD44 and CD31 expression during continuous intravenous administration of G-CSF in normal donors. Stem Cells 2000; 18: 281-286.
10. dim progenitor cells during recombinant human granulocyte-colony-stimulating factor administration in normal donors. Transfusion 1997; 37: 406-410.
11. + cell determination by flow cytometry. J Hematother 1996; 5: 213-226.
12. Miflin G, Charley C, Stainer C et al. Stem cell mobilization in normal donors for allogeneic transplantation: Analysis of safety and factors affecting efficacy. Br J Haematol 1996; 95: 345-348.
13. de Fabritiis P, Iori AP, Mengarelli A et al. CD34+ cell mobilization for allogeneic progenitor cell transplantation: Efficacy of a short course of G-CSF. Transfusion 2001; 41: 190-195.
14. Papayannopoulou T, Priestley GV, Nakamoto B. Anti-VLA4/VCAM-1-induced mobilization requires cooperative signaling through the kit/mkit ligand pathway. Blood 1998; 91: 2231-2239.
15. Craddock CF, Nakamoto B, Andrews RG et al. Antibodies to VLA4 integrin mobilize long-term repopulating cells and augment cytokine-induced mobilization in primates and mice. Blood 1997; 90: 4779-4788.
16. Papayannopoulou T. Mechanisms of stem-/progenitor-cell mobilization: The anti-VLA-4 paradigm. Semin Hematol 2000; 37: 11-18.
17. Liles W, Broxmeyer HE, Rodger E et al. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 2003; 102: 2728-2730.
18. + progenitors to the peripheral blood. J Exp Med 1997; 185: 111-120.
19. Petit I, Szyper-Kravitz M, Nagler A et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and upregulating CXCR4. Nat Immunol 2002; 3: 687-694.
20. + cells: Role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood 2000; 95: 3289-3296.
21. Laterveer L, Lindley IJ, Hamilton MS et al. Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability. Blood 1995; 85: 2269-2275.
22. Fibbe WE, Pruijt JF, van Kooyk Y et al. The role of metalloproteinases and adhesion molecules in interleukin-8-induced stem cell mobilization. Semin Hematol 2000; 37: 19-24.
23. Levesque JP, Takamatsu Y, Nilsson SK et al. Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood 2001; 98: 1289-1297.
24. Matsuzaki G, Li XY, Ohyama Y et al. Kinetics of serum granulocyte-colony stimulating factor (G-CSF) concentration and G-CSF receptor expression during G-CSF treatment of cyclophosphamide-treated mice. Int J Immunopharmacol 1996; 18: 363-369.
25. Yano T, Katayama Y, Sunami K et al. G-CSF-induced mobilization of peripheral blood stem cells for allografting: Comparative study of daily single vs divided dose of G-CSF. Int J Hematol 1997; 66: 169-178.
26. Liu F, Poursine-Laurent J, Link DC. Expression of the G-CSF receptor on hematopoietic progenitor cells in not required for their mobilization by G-CSF. Blood 2000; 95: 3025-3031.